nodes	percent_of_prediction	percent_of_DWPC	metapath
Methsuximide—Hyperaemia—Dexamethasone—ankylosing spondylitis	0.0659	0.0659	CcSEcCtD
Methsuximide—Hyperaemia—Betamethasone—ankylosing spondylitis	0.0659	0.0659	CcSEcCtD
Methsuximide—Hiccups—Prednisolone—ankylosing spondylitis	0.0239	0.0239	CcSEcCtD
Methsuximide—Hiccups—Triamcinolone—ankylosing spondylitis	0.0219	0.0219	CcSEcCtD
Methsuximide—Hiccups—Methylprednisolone—ankylosing spondylitis	0.0219	0.0219	CcSEcCtD
Methsuximide—Hiccups—Betamethasone—ankylosing spondylitis	0.0199	0.0199	CcSEcCtD
Methsuximide—Hiccups—Dexamethasone—ankylosing spondylitis	0.0199	0.0199	CcSEcCtD
Methsuximide—Hiccups—Prednisone—ankylosing spondylitis	0.0173	0.0173	CcSEcCtD
Methsuximide—Proteinuria—Methotrexate—ankylosing spondylitis	0.0165	0.0165	CcSEcCtD
Methsuximide—Protein urine present—Methotrexate—ankylosing spondylitis	0.0163	0.0163	CcSEcCtD
Methsuximide—Psychotic disorder—Methylprednisolone—ankylosing spondylitis	0.0155	0.0155	CcSEcCtD
Methsuximide—Irritability—Methylprednisolone—ankylosing spondylitis	0.0152	0.0152	CcSEcCtD
Methsuximide—Psychotic disorder—Dexamethasone—ankylosing spondylitis	0.0141	0.0141	CcSEcCtD
Methsuximide—Psychotic disorder—Betamethasone—ankylosing spondylitis	0.0141	0.0141	CcSEcCtD
Methsuximide—Irritability—Betamethasone—ankylosing spondylitis	0.0138	0.0138	CcSEcCtD
Methsuximide—Irritability—Dexamethasone—ankylosing spondylitis	0.0138	0.0138	CcSEcCtD
Methsuximide—Psychotic disorder—Prednisone—ankylosing spondylitis	0.0123	0.0123	CcSEcCtD
Methsuximide—Irritability—Prednisone—ankylosing spondylitis	0.012	0.012	CcSEcCtD
Methsuximide—Weight decreased—Betamethasone—ankylosing spondylitis	0.0113	0.0113	CcSEcCtD
Methsuximide—Weight decreased—Dexamethasone—ankylosing spondylitis	0.0113	0.0113	CcSEcCtD
Methsuximide—Irritability—Methotrexate—ankylosing spondylitis	0.01	0.01	CcSEcCtD
Methsuximide—Ataxia—Methotrexate—ankylosing spondylitis	0.00989	0.00989	CcSEcCtD
Methsuximide—Weight decreased—Prednisone—ankylosing spondylitis	0.00984	0.00984	CcSEcCtD
Methsuximide—Vision blurred—Prednisolone—ankylosing spondylitis	0.00983	0.00983	CcSEcCtD
Methsuximide—Eosinophilia—Methotrexate—ankylosing spondylitis	0.009	0.009	CcSEcCtD
Methsuximide—Pancytopenia—Methotrexate—ankylosing spondylitis	0.00863	0.00863	CcSEcCtD
Methsuximide—Drowsiness—Methotrexate—ankylosing spondylitis	0.0081	0.0081	CcSEcCtD
Methsuximide—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.00803	0.00803	CcSEcCtD
Methsuximide—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00787	0.00787	CcSEcCtD
Methsuximide—Haematuria—Methotrexate—ankylosing spondylitis	0.00773	0.00773	CcSEcCtD
Methsuximide—Insomnia—Prednisolone—ankylosing spondylitis	0.0077	0.0077	CcSEcCtD
Methsuximide—Vision blurred—Prednisone—ankylosing spondylitis	0.00714	0.00714	CcSEcCtD
Methsuximide—Insomnia—Triamcinolone—ankylosing spondylitis	0.00708	0.00708	CcSEcCtD
Methsuximide—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00706	0.00706	CcSEcCtD
Methsuximide—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00701	0.00701	CcSEcCtD
Methsuximide—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.00688	0.00688	CcSEcCtD
Methsuximide—Anorexia—Dexamethasone—ankylosing spondylitis	0.00677	0.00677	CcSEcCtD
Methsuximide—Anorexia—Betamethasone—ankylosing spondylitis	0.00677	0.00677	CcSEcCtD
Methsuximide—Urticaria—Prednisolone—ankylosing spondylitis	0.00676	0.00676	CcSEcCtD
Methsuximide—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00645	0.00645	CcSEcCtD
Methsuximide—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00643	0.00643	CcSEcCtD
Methsuximide—Insomnia—Dexamethasone—ankylosing spondylitis	0.00642	0.00642	CcSEcCtD
Methsuximide—Insomnia—Betamethasone—ankylosing spondylitis	0.00642	0.00642	CcSEcCtD
Methsuximide—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00639	0.00639	CcSEcCtD
Methsuximide—Urticaria—Triamcinolone—ankylosing spondylitis	0.00622	0.00622	CcSEcCtD
Methsuximide—Urticaria—Methylprednisolone—ankylosing spondylitis	0.0062	0.0062	CcSEcCtD
Methsuximide—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00617	0.00617	CcSEcCtD
Methsuximide—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.00617	0.00617	CcSEcCtD
Methsuximide—Decreased appetite—Betamethasone—ankylosing spondylitis	0.00617	0.00617	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00613	0.00613	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00613	0.00613	CcSEcCtD
Methsuximide—Vision blurred—Methotrexate—ankylosing spondylitis	0.00597	0.00597	CcSEcCtD
Methsuximide—Anorexia—Prednisone—ankylosing spondylitis	0.00589	0.00589	CcSEcCtD
Methsuximide—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00585	0.00585	CcSEcCtD
Methsuximide—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00585	0.00585	CcSEcCtD
Methsuximide—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00581	0.00581	CcSEcCtD
Methsuximide—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00581	0.00581	CcSEcCtD
Methsuximide—Leukopenia—Methotrexate—ankylosing spondylitis	0.00567	0.00567	CcSEcCtD
Methsuximide—Urticaria—Dexamethasone—ankylosing spondylitis	0.00564	0.00564	CcSEcCtD
Methsuximide—Urticaria—Betamethasone—ankylosing spondylitis	0.00564	0.00564	CcSEcCtD
Methsuximide—Dizziness—Prednisolone—ankylosing spondylitis	0.00563	0.00563	CcSEcCtD
Methsuximide—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00561	0.00561	CcSEcCtD
Methsuximide—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00561	0.00561	CcSEcCtD
Methsuximide—Insomnia—Prednisone—ankylosing spondylitis	0.00559	0.00559	CcSEcCtD
Methsuximide—Decreased appetite—Prednisone—ankylosing spondylitis	0.00538	0.00538	CcSEcCtD
Methsuximide—Rash—Prednisolone—ankylosing spondylitis	0.00537	0.00537	CcSEcCtD
Methsuximide—Dermatitis—Prednisolone—ankylosing spondylitis	0.00536	0.00536	CcSEcCtD
Methsuximide—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00534	0.00534	CcSEcCtD
Methsuximide—Headache—Prednisolone—ankylosing spondylitis	0.00533	0.00533	CcSEcCtD
Methsuximide—Constipation—Prednisone—ankylosing spondylitis	0.00529	0.00529	CcSEcCtD
Methsuximide—Confusional state—Methotrexate—ankylosing spondylitis	0.00521	0.00521	CcSEcCtD
Methsuximide—Dizziness—Triamcinolone—ankylosing spondylitis	0.00517	0.00517	CcSEcCtD
Methsuximide—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00516	0.00516	CcSEcCtD
Methsuximide—Feeling abnormal—Prednisone—ankylosing spondylitis	0.0051	0.0051	CcSEcCtD
Methsuximide—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00506	0.00506	CcSEcCtD
Methsuximide—Nausea—Prednisolone—ankylosing spondylitis	0.00505	0.00505	CcSEcCtD
Methsuximide—Vomiting—Triamcinolone—ankylosing spondylitis	0.00498	0.00498	CcSEcCtD
Methsuximide—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00496	0.00496	CcSEcCtD
Methsuximide—Rash—Triamcinolone—ankylosing spondylitis	0.00493	0.00493	CcSEcCtD
Methsuximide—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00493	0.00493	CcSEcCtD
Methsuximide—Anorexia—Methotrexate—ankylosing spondylitis	0.00493	0.00493	CcSEcCtD
Methsuximide—Rash—Methylprednisolone—ankylosing spondylitis	0.00492	0.00492	CcSEcCtD
Methsuximide—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00492	0.00492	CcSEcCtD
Methsuximide—Urticaria—Prednisone—ankylosing spondylitis	0.00491	0.00491	CcSEcCtD
Methsuximide—Headache—Triamcinolone—ankylosing spondylitis	0.0049	0.0049	CcSEcCtD
Methsuximide—Headache—Methylprednisolone—ankylosing spondylitis	0.00489	0.00489	CcSEcCtD
Methsuximide—Abdominal pain—Prednisone—ankylosing spondylitis	0.00489	0.00489	CcSEcCtD
Methsuximide—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00486	0.00486	CcSEcCtD
Methsuximide—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00486	0.00486	CcSEcCtD
Methsuximide—Dizziness—Betamethasone—ankylosing spondylitis	0.0047	0.0047	CcSEcCtD
Methsuximide—Dizziness—Dexamethasone—ankylosing spondylitis	0.0047	0.0047	CcSEcCtD
Methsuximide—Insomnia—Methotrexate—ankylosing spondylitis	0.00467	0.00467	CcSEcCtD
Methsuximide—Nausea—Triamcinolone—ankylosing spondylitis	0.00465	0.00465	CcSEcCtD
Methsuximide—Nausea—Methylprednisolone—ankylosing spondylitis	0.00464	0.00464	CcSEcCtD
Methsuximide—Somnolence—Methotrexate—ankylosing spondylitis	0.00459	0.00459	CcSEcCtD
Methsuximide—Vomiting—Betamethasone—ankylosing spondylitis	0.00451	0.00451	CcSEcCtD
Methsuximide—Vomiting—Dexamethasone—ankylosing spondylitis	0.00451	0.00451	CcSEcCtD
Methsuximide—Decreased appetite—Methotrexate—ankylosing spondylitis	0.00449	0.00449	CcSEcCtD
Methsuximide—Rash—Betamethasone—ankylosing spondylitis	0.00448	0.00448	CcSEcCtD
Methsuximide—Rash—Dexamethasone—ankylosing spondylitis	0.00448	0.00448	CcSEcCtD
Methsuximide—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00447	0.00447	CcSEcCtD
Methsuximide—Dermatitis—Betamethasone—ankylosing spondylitis	0.00447	0.00447	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.00446	0.00446	CcSEcCtD
Methsuximide—Headache—Betamethasone—ankylosing spondylitis	0.00445	0.00445	CcSEcCtD
Methsuximide—Headache—Dexamethasone—ankylosing spondylitis	0.00445	0.00445	CcSEcCtD
Methsuximide—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00426	0.00426	CcSEcCtD
Methsuximide—Diarrhoea—Prednisone—ankylosing spondylitis	0.00423	0.00423	CcSEcCtD
Methsuximide—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00423	0.00423	CcSEcCtD
Methsuximide—Nausea—Dexamethasone—ankylosing spondylitis	0.00422	0.00422	CcSEcCtD
Methsuximide—Nausea—Betamethasone—ankylosing spondylitis	0.00422	0.00422	CcSEcCtD
Methsuximide—Urticaria—Methotrexate—ankylosing spondylitis	0.00411	0.00411	CcSEcCtD
Methsuximide—Dizziness—Prednisone—ankylosing spondylitis	0.00409	0.00409	CcSEcCtD
Methsuximide—Abdominal pain—Methotrexate—ankylosing spondylitis	0.00409	0.00409	CcSEcCtD
Methsuximide—Vomiting—Prednisone—ankylosing spondylitis	0.00393	0.00393	CcSEcCtD
Methsuximide—Rash—Prednisone—ankylosing spondylitis	0.0039	0.0039	CcSEcCtD
Methsuximide—Dermatitis—Prednisone—ankylosing spondylitis	0.0039	0.0039	CcSEcCtD
Methsuximide—Headache—Prednisone—ankylosing spondylitis	0.00387	0.00387	CcSEcCtD
Methsuximide—Nausea—Prednisone—ankylosing spondylitis	0.00367	0.00367	CcSEcCtD
Methsuximide—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00354	0.00354	CcSEcCtD
Methsuximide—Dizziness—Methotrexate—ankylosing spondylitis	0.00342	0.00342	CcSEcCtD
Methsuximide—Vomiting—Methotrexate—ankylosing spondylitis	0.00329	0.00329	CcSEcCtD
Methsuximide—Rash—Methotrexate—ankylosing spondylitis	0.00326	0.00326	CcSEcCtD
Methsuximide—Dermatitis—Methotrexate—ankylosing spondylitis	0.00326	0.00326	CcSEcCtD
Methsuximide—Headache—Methotrexate—ankylosing spondylitis	0.00324	0.00324	CcSEcCtD
Methsuximide—Nausea—Methotrexate—ankylosing spondylitis	0.00307	0.00307	CcSEcCtD
